Fasenra pen 30 MG/mlml
Ended Awarded Last action
- Contract number
- SPE2DR26FHNV6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,494
Award facts
- Contract value 100% obligated
- $2,493.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,493.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for FASENRA PEN 30 MG/ML. The award was issued on January 26, 2026, under a firm fixed-price contract structure with an ultimate completion date of January 27, 2026. No set-aside designation was used for this procurement. DMS Pharmaceutical Group Inc., which has been registered in the System for Award Management since 2001, serves as a critical supplier within the federal pharmaceutical supply chain, particularly for the Department of Defense.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which carries a $499.999 billion ceiling value and extends through December 31, 2036. The PPV-G GEN V program represents a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical sourcing for Department of Defense military healthcare facilities worldwide. The company's established performance across multiple delivery orders and its extensive product portfolio—spanning branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals—position it as a key regional prime vendor contractor within this strategic program.
Quick answers
Who was awarded contract SPE2DR26FHNV6?
SPE2DR26FHNV6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FHNV6 worth?
The government has obligated $2,494 on SPE2DR26FHNV6.
Is contract SPE2DR26FHNV6 an order under another contract?
Yes. SPE2DR26FHNV6 is a delivery order under SPE2DR25D9231, an indefinite delivery contract.
Was contract SPE2DR26FHNV6 competed?
The extent of competition for SPE2DR26FHNV6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award